Literature DB >> 9278227

DNA transfer into vascular smooth muscle using fusigenic Sendai virus (HVJ)-liposomes.

M J Mann1, R Morishita, G H Gibbons, H E von der Leyen, V J Dzau.   

Abstract

Manipulation of the genetic machinery of cells both in vitro and in vivo is becoming an ever more important means of elucidating pathways of molecular and cellular biochemistry. In addition, gene therapy has been proposed as a novel and potentially powerful treatment for both inherited and acquired diseases. Successful gene transfer and gene blockade generally depend on high efficiency delivery of exogenous DNA or RNA into living cells, and much effort has therefore been focused on the development of methods for achieving this delivery in a safe and effective manner. We describe here our application of fusigenic Sendai virus (HVJ)-liposome technology toward the effective delivery of DNA into vascular smooth muscle cells (VSMC) in cell culture. Cellular uptake and intracellular distribution of oligodeoxynucleotide (ODN) after transfection with HVJ-liposome complexes was characterized using fluorescent (FITC)-labeled ODN, and the biologic effect of HVJ-liposome mediated transfection was demonstrated via inhibition of DNA synthesis in cultured VSMC using antisense ODN against basic fibroblast growth factor.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9278227

Source DB:  PubMed          Journal:  Mol Cell Biochem        ISSN: 0300-8177            Impact factor:   3.396


  21 in total

1.  An improved large scale fractionation of high mobility group non-histone chromatin proteins.

Authors:  G H Goodwin; R H Nicolas; E W Johns
Journal:  Biochim Biophys Acta       Date:  1975-10-20

2.  Analysis of giant polynuclear cell formation caused by HVJ virus from Ehrlich's ascites tumor cells. II. Quantitative analysis of giant polynuclear cell formation.

Authors:  Y OKADA; J TADOKORO
Journal:  Exp Cell Res       Date:  1962-02       Impact factor: 3.905

3.  Arterial gene transfer to rabbit endothelial and smooth muscle cells using percutaneous delivery of an adenoviral vector.

Authors:  P G Steg; L J Feldman; J Y Scoazec; O Tahlil; J J Barry; S Boulechfar; T Ragot; J M Isner; M Perricaudet
Journal:  Circulation       Date:  1994-10       Impact factor: 29.690

4.  Adenovirus as an expression vector in muscle cells in vivo.

Authors:  B Quantin; L D Perricaudet; S Tajbakhsh; J L Mandel
Journal:  Proc Natl Acad Sci U S A       Date:  1992-04-01       Impact factor: 11.205

5.  Binding, uptake, and intracellular trafficking of phosphorothioate-modified oligodeoxynucleotides.

Authors:  C Beltinger; H U Saragovi; R M Smith; L LeSauteur; N Shah; L DeDionisio; L Christensen; A Raible; L Jarett; A M Gewirtz
Journal:  J Clin Invest       Date:  1995-04       Impact factor: 14.808

6.  Multiple autocrine growth factors modulate vascular smooth muscle cell growth response to angiotensin II.

Authors:  H Itoh; M Mukoyama; R E Pratt; G H Gibbons; V J Dzau
Journal:  J Clin Invest       Date:  1993-05       Impact factor: 14.808

7.  Genetic engineering of vein grafts resistant to atherosclerosis.

Authors:  M J Mann; G H Gibbons; R S Kernoff; F P Diet; P S Tsao; J P Cooke; Y Kaneda; V J Dzau
Journal:  Proc Natl Acad Sci U S A       Date:  1995-05-09       Impact factor: 11.205

8.  Glomerulosclerosis induced by in vivo transfection of transforming growth factor-beta or platelet-derived growth factor gene into the rat kidney.

Authors:  Y Isaka; Y Fujiwara; N Ueda; Y Kaneda; T Kamada; E Imai
Journal:  J Clin Invest       Date:  1993-12       Impact factor: 14.808

9.  Entrapment of a bacterial plasmid in phospholipid vesicles: potential for gene transfer.

Authors:  R T Fraley; C S Fornari; S Kaplan
Journal:  Proc Natl Acad Sci U S A       Date:  1979-07       Impact factor: 11.205

10.  Oligonucleotide-cationic liposome interactions. A physicochemical study.

Authors:  I Jääskeläinen; J Mönkkönen; A Urtti
Journal:  Biochim Biophys Acta       Date:  1994-10-12
View more
  3 in total

1.  Pressure-mediated oligonucleotide transfection of rat and human cardiovascular tissues.

Authors:  M J Mann; G H Gibbons; H Hutchinson; R S Poston; E G Hoyt; R C Robbins; V J Dzau
Journal:  Proc Natl Acad Sci U S A       Date:  1999-05-25       Impact factor: 11.205

Review 2.  Gene therapy for renal disorders: what are the benefits for the elderly?

Authors:  Yeong-Hau H Lien; Li-Wen Lai
Journal:  Drugs Aging       Date:  2002       Impact factor: 3.923

3.  Sendai virus-based liposomes enable targeted cytosolic delivery of nanoparticles in brain tumor-derived cells.

Authors:  Veronica Dudu; Veronica Rotari; Maribel Vazquez
Journal:  J Nanobiotechnology       Date:  2012-02-17       Impact factor: 10.435

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.